DNA Detectives

VC-backed 23andMe and Navigenics say consumers are eager to have their genes analyzed, but the high price and other factors may dampen demand

1 April 2008•8 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.